Literature DB >> 3033266

Map position and nucleotide sequence of the gene for the large structural phosphoprotein of human cytomegalovirus.

G Jahn, T Kouzarides, M Mach, B C Scholl, B Plachter, B Traupe, E Preddie, S C Satchwell, B Fleckenstein, B G Barrell.   

Abstract

Human cytomegalovirus particles contain a phosphoprotein of 150,000 (pp150) apparent molecular weight in their matrix; the protein appears particularly reactive in Western blot analyses with human antisera. The gene for pp150 was mapped by screening a bacteriophage lambda gt11 cDNA expression library with monospecific rabbit antisera. Subsequent hybridization of cDNA with cosmid and plasmid clones containing the human cytomegalovirus strain AD169 genome mapped the gene to HindIII fragments J and N. The gene is transcribed into a late 6.2-kilobase RNA. The nucleotide sequence of this region was determined, and a transcription initiation site and two polyadenylation sites of an abundant transcript were located by primer extension and nuclease protection experiments. The reading frame for pp150, deduced from computer analyses, gives rise to a polypeptide of 1,048 amino acids in length; protein secondary structure analysis revealed multiple beta-pleated sheets in hydrophilic clusters, providing a possible explanation for the immunogenic properties of the polypeptide.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033266      PMCID: PMC254110          DOI: 10.1128/JVI.61.5.1358-1367.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid.

Authors:  A C Chang; S N Cohen
Journal:  J Bacteriol       Date:  1978-06       Impact factor: 3.490

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins.

Authors:  C R Merril; D Goldman; S A Sedman; M H Ebert
Journal:  Science       Date:  1981-03-27       Impact factor: 47.728

5.  Primary structure and transcription of the genes coding for the two virion phosphoproteins pp65 and pp71 of human cytomegalovirus.

Authors:  B Rüger; S Klages; B Walla; J Albrecht; B Fleckenstein; P Tomlinson; B Barrell
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

6.  Herpes simplex virus phosphoproteins. II. Characterization of the virion protein kinase and of the polypeptides phosphorylated in the virion.

Authors:  S Lemaster; B Roizman
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

7.  Human cytomegalovirus: purification of enveloped virions and dense bodies.

Authors:  P Talbot; J D Almeida
Journal:  J Gen Virol       Date:  1977-08       Impact factor: 3.891

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Human cytomegalovirus: glycoproteins associated with virions and dense bodies.

Authors:  M F Stinski
Journal:  J Virol       Date:  1976-08       Impact factor: 5.103

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  47 in total

1.  Cytomegalovirus basic phosphoprotein (pUL32) binds to capsids in vitro through its amino one-third.

Authors:  M K Baxter; W Gibson
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Functional analysis of the true late human cytomegalovirus pp28 upstream promoter: cis-acting elements and viral trans-acting proteins necessary for promoter activation.

Authors:  A S Depto; R M Stenberg
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  Large-scale screening of human sera with cytomegalovirus recombinant antigens.

Authors:  M P Landini; M X Guan; G Jahn; W Lindenmaier; M Mach; A Ripalti; A Necker; T Lazzarotto; B Plachter
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

4.  Cloning and characterization of major antigenic determinants of human cytomegalovirus Ad169 seen by the human immune system.

Authors:  W Lindenmaier; A Necker; S Krause; R Bonewald; J Collins
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

5.  Human cytomegalovirus structural proteins: immune reaction against pp150 synthetic peptides.

Authors:  M P Landini; A Ripalti; K Sra; P Pouletty
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

6.  Characterization of human cytomegalovirus UL84 early gene and identification of its putative protein product.

Authors:  Y S He; L Xu; E S Huang
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

7.  Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection.

Authors:  C Söderberg; S Larsson; S Bergstedt-Lindqvist; E Möller
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Spliced transcripts of human cytomegalovirus.

Authors:  W D Rawlinson; B G Barrell
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

9.  Site-specific glycosylation of the human cytomegalovirus tegument basic phosphoprotein (UL32) at serine 921 and serine 952.

Authors:  K D Greis; W Gibson; G W Hart
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Bicaudal D1-dependent trafficking of human cytomegalovirus tegument protein pp150 in virus-infected cells.

Authors:  Sabarish V Indran; Mary E Ballestas; William J Britt
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.